%20(3).png?width=1000&height=375&name=ISPOR%20Hubspot%20Banner%20(924%20%C3%97%20375%20px)%20(3).png "ISPOR Hubspot Banner (924 × 375 px) (3)")
Connect with us at ISPOR
Join us and connect with our team of experts and attend our speaking sessions to learn the latest oncology research discoveries. Visit Syapse at booth #206 and join us at our cocktail reception!
We will be presenting 13 poster presentations during ISPOR, take a look at our session schedule.
Come socialize with Syapse before ISPOR starts
Join Team Syapse and other ISPOR attendees for a casual cocktail reception before ISPOR starts Monday morning. Complimentary cocktails and heavy apps will be provided.
Date: Sunday, May 15
Time: 7:00p EST
Location: Succotash, 186 Waterfront St
Click the links to learn more about our research and expertise
Peer-reviewed research: Prep with our latest publications and previous ISPOR posters
Video: Hear from industry luminary Otis Brawley, MD, Bloomberg Distinguished Professor, Johns Hopkins University, and his peers about how they are reducing healthcare disparities
Blog: Discover the critical steps to create trusted data and evidence that helps improve patients’ lives
Blog: Embark on the future of RWE with data science and collaboration
See what our clients, collaborators, and industry experts have to say about us
Andy Schmeltz, global president & general manager, Pfizer Oncology
“RWE is critical to understanding treatment journeys of people with cancer - it allows us to make smarter decisions, accelerate medicine development and personalized care, and helps ensure patients receive the right medicines at the right time. Our collaboration with Syapse and its network of health system partners helps us analyze RWD in breast cancer.”
George Prendergast, PhD, president and CEO of LIMR, Main Line Health
“Syapse’s technology puts Main Line Health at the cutting edge of biomedical research in clinical oncology and will benefit our patients tremendously. This data-driven approach will ensure our patients know if they are eligible for a clinical trial of a potentially life-saving targeted therapy. Clearly, this is a direction that hospital systems nationwide should be headed.”
Zoheb Hassan, senior consultant at Frost & Sullivan
“Syapse ensures patient-centric, quality care by transforming RWE into actionable insights, positively impacting cancer patients’ care and outcomes. Its unrivaled Syapse Learning Health Network platform allows healthcare providers to improve cancer care by sharing RWD that supports decision-making among industry stakeholders to ultimately transform patient care.”